Skip to content

Marketstatics

Menu
  • Home
  • About Us
  • Contact Us
Menu

Category: Pharmaceutical

FVIII Afstyla Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

FVIII Afstyla Market Size and Forecast Afstyla (Antihemophilic Factor, Recombinant, Single Chain) is a notable product within the global Factor VIII (FVIII) market for Hemophilia A treatment. The FVIII market as a…

MOH Venlafaxine Low Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Venlafaxine Market Size and Forecast The global Venlafaxine market size was estimated at USD 3.482 billion in 2024. As a key antidepressant, Venlafaxine (an SNRI) addresses Major Depressive Disorder (MDD) and Generalized…

AS Mirikizumab Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

AS Mirikizumab Market Size and Forecast Mirikizumab, branded as Omvoh and developed by Eli Lilly, is an interleukin-23 (IL-23) inhibitor approved for the treatment of moderately to severely active ulcerative colitis and…

HD Deutetrabenazine Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

HD Deutetrabenazine Market Size and Forecast The global Deutetrabenazine market is expanding significantly, fueled by its approval for treating chorea associated with Huntington’s disease (HD) and tardive dyskinesia. In 2024, the market…

Emi for Hem C Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Emicizumab for Hemophilia C Market Size and Forecast The market for Emicizumab (Hemlibra) in Hemophilia C is highly specialized, targeting a small but high-value patient population. While specific market size data for…

Thal Luspatercept Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Luspatercept Market Size and Forecast The Luspatercept (Reblozyl) market represents a specialized and growing segment within the treatment landscape for hematologic disorders, primarily focused on beta-thalassemia and myelodysplastic syndromes (MDS) associated anemia….

HS Adalimumab Biosims Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

HS Adalimumab Biosims Market Size and Forecast The Adalimumab biosimilar market is experiencing explosive growth, fueled by the patent expiration of Humira (adalimumab) and subsequent launches of biosimilars globally, especially in key…

Autism Memantine Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Autism Memantine Market Size and Forecast The market for Memantine in Autism Spectrum Disorder (ASD) is currently niche, as Memantine is primarily approved for Alzheimer’s disease but used off-label or under investigation…

VWD LFB Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Von Willebrand Disease (VWD) Treatment Market Size and Forecast The global Von Willebrand Disease (VWD) Treatment Market is growing steadily due to the increasing prevalence of this genetic bleeding disorder and improved…

pJIA Tocilizumab Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

pJIA Tocilizumab Market Size and Forecast Tocilizumab, marketed as Actemra, plays a crucial role in treating polyarticular juvenile idiopathic arthritis (pJIA) by targeting the interleukin-6 (IL-6) receptor. While the global Tocilizumab market…

Posts pagination

Previous 1 … 27 28 29 … 101 Next

Categories

  • Healthcare
  • Pharmaceutical
  • Uncategorized
©2025 Marketstatics | Design: Newspaperly WordPress Theme